CABALETTA BIO, INC. (CABA): Price and Financial Metrics
CABALETTA BIO, INC. (CABA)
Today's Latest Price: $11.59 USD
Updated Oct 22 4:00pm
Add CABA to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CABA Stock Price Chart Interactive Chart >
CABA Price/Volume Stats
| Current price | $11.59 | 52-week high | $19.63 |
| Prev. close | $11.55 | 52-week low | $5.51 |
| Day low | $11.15 | Volume | 46,600 |
| Day high | $11.73 | Avg. volume | 105,618 |
| 50-day MA | $11.05 | Dividend yield | N/A |
| 200-day MA | $10.86 | Market Cap | 278.62M |
CABALETTA BIO, INC. (CABA) Company Bio
Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in 2017 and is headquartered in Philadelphia, PA.
Loading social stream, please wait...